ABBAH: ACTIVITY BREAKS FOR BRAIN HEALTH. A PROTOCOL FOR A RANDOMIZED CROSSOVER TRIAL


Conventional Therapies Deplete Brain-Infiltrating Adaptive Immune Cells in a Mouse Model of Group 3 Medulloblastoma Implicating Myeloid Cells as Favorable Immunotherapy Targets

Medulloblastoma is the most common childhood brain cancer.Mainstay treatments of radiation and chemotherapy have not changed in decades and new treatment approaches are crucial for the improvement of clinical outcomes.To date, immunotherapies for medulloblastoma have been unsuccessful, and studies investigating the immune microenvironment of the di

read more